KJIM :: Korean Journal of Internal Medicine

Impact of COVID-19 pandemic among patients with lung and head and neck cancer assisted in a public cancer center in Brazil

Gilson Gabriel Viana Veloso, Flávia Duarte Amaral, Angélica Nogueira-Rodrigues

Tyrosine kinase inhibitors in cancers: Treatment optimization – Part II

Florent Ferrer, Pauline Tetu, Léa Dousset, Céleste Lebbe, Joseph Ciccolini, David Combarel, Nicolas Meyer, Angelo Paci, Stéphane Bouchet

Critical Reviews in Oncology/Hematology.2024; 200: 104385. CrossRef

Risk factors of poor nutrition in non-small cell lung cancer patients after chemotherapy: cross-sectional study

Nutritional assessment and quality of life in patients with non-small cell lung cancer undergoing immunotherapy

Theocharis Konstantinidis, Chrysi Fragkioudaki, Evridiki Patelarou, Michail Zografakis-Sfakianakis, Symeon Naoum, Ioanna Tsatsou, Ioannis Kalemikerakis, Ourania Govina

International Journal of Palliative Nursing.2023; 29(3): 118. CrossRef

Research progress and value of albumin-related inflammatory markers in the prognosis of non-small cell lung cancer: a review of clinical evidence

Chuan-long Zhang, Meng-qi Gao, Xiao-chen Jiang, Xue Pan, Xi-yuan Zhang, Yi Li, Qian Shen, Yan Chen, Bo Pang

The real‐world clinical outcomes and treatment patterns of patients with unresectable locally advanced or metastatic soft tissue sarcoma treated with anlotinib in the post‐ALTER0203 trial era

Ren‐Shu Zhang, Jie Liu, Yao‐Tiao Deng, Xin Wu, Yu Jiang

Switch to EGFR-TKI after upfront platinum doublet induction therapy in non-small cell lung cancer (NSCLC) patients with EGFR (Epidermal Growth Factor Receptor) mutation: A multicentre retrospective study

Susana Baptista de Almeida, Ana Sofia Spencer, Claudia Lares dos Santos, Gonçalo Fernandes, Pedro Simões, Sónia Silva, Tiago Dias Domingues, Marta Honório

Cancer Treatment and Research Communications.2022; 31: 100526. CrossRef

Association Between Obesity and Poor Prognosis in Patients Receiving Anlotinib for Advanced Non-Small Cell Lung Cancer

Anning Xiong, Wei Nie, Lei Cheng, Hua Zhong, Tianqing Chu, Runbo Zhong, Jun Lu, Shuyuan Wang, Jianlin Xu, Yinchen Shen, Feng Pan, Baohui Han, Xueyan Zhang

Predicting Outcomes in NSCLC: Staging or Biology or Both?

Journal of Investigative Surgery.2021; 34(4): 441. CrossRef

Expected and paradoxical effects of obesity on cancer treatment response

Marco Gallo, Valerio Adinolfi, Viola Barucca, Natalie Prinzi, Valerio Renzelli, Luigi Barrea, Paola Di Giacinto, Rosaria Maddalena Ruggeri, Franz Sesti, Emanuela Arvat, Roberto Baldelli, Emanuela Arvat, Annamaria Colao, Andrea Isidori, Andrea Lenzi, Rober

Reviews in Endocrine and Metabolic Disorders.2021; 22(4): 681. CrossRef

Impact of body composition, nutritional and inflammatory status on outcome of non-small cell lung cancer patients treated with immunotherapy

Cinzia Baldessari, Giorgia Guaitoli, Filippo Valoriani, Riccardo Bonacini, Raffaella Marcheselli, Linda Reverberi, Annarita Pecchi, Renata Menozzi, Pietro Torricelli, Federica Bertolini, Fausto Barbieri, Massimo Dominici

Is the prognostic nutritional index a prognostic and predictive factor in metastatic non-small cell lung cancer patients treated with first-line chemotherapy?

Yakup Bozkaya, Osman Köstek, Abdullah Sakin, Deniz Tataroğlu Özyükseler, Teoman Şakalar, İbrahim Çil

Supportive Care in Cancer.2020; 28(5): 2273. CrossRef

Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non‐small cell lung cancer receiving EGFR‐TKI treatment

Norimitsu Kasahara, Hisao Imai, Ichiro Naruse, Yusuke Tsukagoshi, Mie Kotake, Noriaki Sunaga, Kyoichi Kaira, Toshitaka Maeno, Takayuki Asao, Takeshi Hisada

Prognostic Value of Pre-Treatment Prognostic Nutritional Index in Esophageal Cancer: A Systematic Review and Meta-Analysis

Jianqi Hao, Cong Chen, Fangfang Wan, Yuzhou Zhu, Hongyu Jin, Jian Zhou, Nan Chen, Jing Yang, Qiang Pu

Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors

Karam Khaddour, Sandra L. Gomez-Perez, Nikita Jain, Jyoti D. Patel, Yanis Boumber

Staging of nutrition disorders in non‐small‐cell lung cancer patients: utility of skeletal muscle mass assessment

Sami Antoun, Hugues Morel, Pierre‐Jean Souquet, Veerle Surmont, David Planchard, Franck Bonnetain, Pascal Foucher, Thomas Egenod, Ivan Krakowski, Hélène Gaudin, Didier Debieuvre

Journal of Cachexia, Sarcopenia and Muscle.2019; 10(4): 782. CrossRef

Muscle derangement and alteration of the nutritional machinery in NSCLC

Ilaria Trestini, Anastasios Gkountakos, Luisa Carbognin, Alice Avancini, Massimo Lanza, Alessio Molfino, Simonetta Friso, Vincenzo Corbo, Giampaolo Tortora, Aldo Scarpa, Michele Milella, Emilio Bria, Sara Pilotto

Critical Reviews in Oncology/Hematology.2019; 141: 43. CrossRef

Body mass index and mortality in lung cancer patients: a systematic review and meta-analysis

J Wang, H Xu, S Zhou, D Wang, L Zhu, J Hou, J Tang, J Zhao, S Zhong

European Journal of Clinical Nutrition.2018; 72(1): 4. CrossRef

Closing the Gap in Nutrition Care at Outpatient Cancer Centers: Ongoing Initiatives of the Oncology Nutrition Dietetic Practice Group

Elaine B. Trujillo, Suzanne W. Dixon, Katrina Claghorn, Rhone M. Levin, Jeannine B. Mills, Colleen K. Spees

Journal of the Academy of Nutrition and Dietetics.2018; 118(4): 749. CrossRef

Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: Review and meta-analysis

Zhongtao Wang, Yongjun Wang, Xinmei Zhang, Tingting Zhang

Prognostic value of pretreatment prognostic nutritional index in non-small cell lung cancer: A systematic review and meta-analysis

Yuanyuan Hu, Jie Shen, RuiKe Liu, ZhiMei Feng, ChangNing Zhang, Li Ling, LiBo Chen

The International Journal of Biological Markers.2018; 33(4): 372. CrossRef

The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis

Yaqi Huang, Siqi Wei, Nan Jiang, Lijuan Zhang, Siyuan Wang, Xiaona Cao, Yue Zhao, Peiguo Wang